Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 12,100 shares at $4.99 ($60K) on 2024-05-22, disclosed to the SEC on 2024-05-23.
Open-market purchase of $60k TMCI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |
| TMCI | SELL | 2023-03-31 | $3.4M | — | Filing → |